Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis

The established biomarker for hepatocellular carcinoma (HCC), serum α-fetoprotein (AFP), has suboptimal performance in early disease stages. This study aimed to develop a metabolite panel to differentiate early-stage HCC from cirrhosis. Cross-sectional metabolomic analyses of serum samples...

Full description

Bibliographic Details
Main Authors: Da Jung Kim, Eun Ju Cho, Kyung-Sang Yu, In-Jin Jang, Jung-Hwan Yoon, Taesung Park, Joo-Youn Cho
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cancers
Subjects:
hepatocellular carcinoma
cirrhosis
metabolomics
biomarker
Online Access:https://www.mdpi.com/2072-6694/11/10/1497

Internet

https://www.mdpi.com/2072-6694/11/10/1497

Similar Items